Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL)

1

Review clinical trials related to Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry

Anaplastic large cell lymphoma associated with breast implants (BIA-ALCL) is a rare disease seen only in women with a breast implant. Because of the low incidence of this disease and the peculiar histological subtype, French authorities, in accordance with the recommendations of an expert group, recommended the implementation of a BIA-ALCL case registry, in connection with a national Multidisciplinary meeting (Réunion de Concertation Pluridisciplinaire nationale de recours- RCP). This registry is opened in France and in Belgium

Participants needed: 150
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: The Lymphoma Academic Research OrganisationUpdated: Jan 14, 2026Locations: 31Duration: 13 Years
Eligibility criteria

Adult patients with an anaplastic large cell lymphoma associated with breast imp...